Clinical Trials Browser

Phase 2 × Active not recruiting × HMPL-013 × Clear all

NCT06356597 2026-02-24

Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05177068 2025-10-02

Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer

Phase 2 Active not recruiting

Gastrointestinal

Stomach Neoplasms